1. Biopharmaceutical Leader Robert J. Spiegel, Md, FACP Appointed to the Athenex Board of Directors

    Biopharmaceutical Leader Robert J. Spiegel, Md, FACP Appointed to the Athenex Board of Directors

    Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the appointment of Robert J. Spiegel, MD, FACP, a renowned biotech and pharmaceutical executive, to its Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. We are thrilled to add an industry executive with Dr. Spiegel's deep drug development expertise to our Board of Directors.
    2. Athenex has an innovative Orascovery platform that can potentially transform chemotherapies and improve patients' lives.  I am excited to join the Athenex Board of Directors and to help the Company further advance their broad clinical pipeline and bring important innovative products to cancer patients.
  3. Topics Mentioned

  4. Authors